{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:18:04Z","timestamp":1788297484020,"version":"build-2803163510"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"DOI":"10.7759\/cureus.115611","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:01:35Z","timestamp":1788296495000},"source":"Crossref","is-referenced-by-count":0,"title":["Audit of Retinal Screening Protocol Adherence Among Patients Receiving Hydroxychloroquine at the Department of Rheumatology, Gulab Devi Teaching Hospital, Pakistan"],"prefix":"10.7759","author":[{"given":"Muhammad Mansoor","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor","family":"Ehsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Abbas","family":"Zahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masem","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usman","family":"Amjad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Zubair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2025.13467","article-title":"Hydroxychloroquine: a double\u2011edged sword (review)","volume":"31","author":"Huo R","year":"2025","unstructured":"Huo R, Wei C, Yang Y, Lin J, Huang X. Hydroxychloroquine: a double\u2011edged sword (review). Mol Med Rep. 2025, 31:10.3892\/mmr.2025.13467","journal-title":"Mol Med Rep"},{"key":"ref2","article-title":"Retinal toxicity in patients treated with hydroxychloroquine: a cross-sectional study","volume":"5","author":"Espandar G","year":"2016","unstructured":"Espandar G, Moghimi J, Ghorbani R, Pourazizi M, Seiri MA, Khosravi S. Retinal toxicity in patients treated with hydroxychloroquine: a cross-sectional study. Med Hypothesis Discov Innov Ophthalmol. 2016, 5:41-6.","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9570.1000e117","article-title":"Screening and diagnosis of hydroxychloroquine toxicity: advances and controversies","volume":"7","author":"Weinlander E","year":"2016","unstructured":"Weinlander E, Ringeisen AL, Mititelu M. Screening and diagnosis of hydroxychloroquine toxicity: advances and controversies. J Clin Exp Ophthalmol. 2016, 7:1-4. 10.4172\/2155-9570.1000e117","journal-title":"J Clin Exp Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab844","article-title":"Risk of hydroxychloroquine retinopathy in the community","volume":"61","author":"Dabit JY","year":"2022","unstructured":"Dabit JY, Hocaoglu M, Moder KG, et al.. Risk of hydroxychloroquine retinopathy in the community. Rheumatology (Oxford). 2022, 61:3172-9. 10.1093\/rheumatology\/keab844","journal-title":"Rheumatology (Oxford)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1196783","article-title":"Hydroxychloroquine-induced retinal toxicity","volume":"14","author":"Yusuf IH","year":"2023","unstructured":"Yusuf IH, Charbel Issa P, Ahn SJ. Hydroxychloroquine-induced retinal toxicity. Front Pharmacol. 2023, 14:1196783. 10.3389\/fphar.2023.1196783","journal-title":"Front Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.10.029","article-title":"Long-term progression of pericentral hydroxychloroquine retinopathy","volume":"128","author":"Ahn SJ","year":"2021","unstructured":"Ahn SJ, Seo EJ, Kim KE, et al.. Long-term progression of pericentral hydroxychloroquine retinopathy. Ophthalmology. 2021, 128:889-98. 10.1016\/j.ophtha.2020.10.029","journal-title":"Ophthalmology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.01.058","article-title":"Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision)","volume":"123","author":"Marmor MF","year":"2016","unstructured":"Marmor MF, Kellner U, Lai TY, Melles RB, Mieler WF. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision). Ophthalmology. 2016, 123:1386-94. 10.1016\/j.ophtha.2016.01.058","journal-title":"Ophthalmology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-020-01380-2","article-title":"The Royal College of Ophthalmologists recommendations on monitoring for hydroxychloroquine and chloroquine users in the United Kingdom (2020 revision): executive summary","volume":"35","author":"Yusuf IH","year":"2021","unstructured":"Yusuf IH, Foot B, Lotery AJ. The Royal College of Ophthalmologists recommendations on monitoring for hydroxychloroquine and chloroquine users in the United Kingdom (2020 revision): executive summary. Eye (Lond). 2021, 35:1532-7. 10.1038\/s41433-020-01380-2","journal-title":"Eye (Lond)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2016.298","article-title":"Hydroxychloroquine retinopathy","volume":"31","author":"Yusuf IH","year":"2017","unstructured":"Yusuf IH, Sharma S, Luqmani R, Downes SM. Hydroxychloroquine retinopathy. Eye (Lond). 2017, 31:828-45. 10.1038\/eye.2016.298","journal-title":"Eye (Lond)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/24741264221097806","article-title":"Compliance with hydroxychloroquine screening guidelines at a large academic medical center","volume":"6","author":"Islam YF","year":"2022","unstructured":"Islam YF, Stroman WR, Steigleman WA. Compliance with hydroxychloroquine screening guidelines at a large academic medical center. J Vitreoretin Dis. 2022, 6:271-7. 10.1177\/24741264221097806","journal-title":"J Vitreoretin Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4236\/ojoph.2025.153015","article-title":"Adherence of ophthalmologists and rheumatologist to the latest recommendations of HCQ retinopathy screening in Saudi Arabia","volume":"8","author":"Althiabi SM","year":"2025","unstructured":"Althiabi SM, Alanazi AM, Alahmary MA, Althobaiti GA, Alqahtani FM, Alotaibi AF, Alsuhaym FM. Adherence of ophthalmologists and rheumatologist to the latest recommendations of HCQ retinopathy screening in Saudi Arabia. Open J Ophthalmol. 2025, 8:105-14. 10.4236\/ojoph.2025.153015","journal-title":"Open J Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rky013","article-title":"An audit of the use of hydroxychloroquine in rheumatology clinics","volume":"2","author":"Worth C","year":"2018","unstructured":"Worth C, Yusuf IH, Turner B, et al.. An audit of the use of hydroxychloroquine in rheumatology clinics. Rheumatol Adv Pract. 2018, 2:rky013. 10.1093\/rap\/rky013","journal-title":"Rheumatol Adv Pract"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.14816","article-title":"Practice patterns of screening for hydroxychloroquine retinopathy in South Korea","volume":"6","author":"Kim J","year":"2023","unstructured":"Kim J, Kim KE, Kim JH, Ahn SJ. Practice patterns of screening for hydroxychloroquine retinopathy in South Korea. JAMA Netw Open. 2023, 6:e2314816. 10.1001\/jamanetworkopen.2023.14816","journal-title":"JAMA Netw Open"},{"key":"ref14","article-title":"Hydroxychloroquine screening adherence: insights from Highmark claims data","volume":"76","author":"Shahid S","year":"2024","unstructured":"Shahid S, Barrett T, Manocha S, Bichile T. Hydroxychloroquine screening adherence: insights from Highmark claims data. Arthritis Rheumatol. 2024, 76:","journal-title":"Arthritis Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.37018\/zbsl5515","article-title":"Screening the adequacy of hydroxychloroquine prescription and monitoring of ocular toxicity in patients with rheumatic disease","volume":"15","author":"Khan SE","year":"2020","unstructured":"Khan SE, Aslam MZ, Khan A, Din ZU, Bashir F, Khan H. Screening the adequacy of hydroxychloroquine prescription and monitoring of ocular toxicity in patients with rheumatic disease. J Fatima Jinnah Med Univ. 2020, 15:128-31. 10.37018\/zbsl5515","journal-title":"J Fatima Jinnah Med Univ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.5527\/wjn.v3.i4.249","article-title":"Clinical audit, a valuable tool to improve quality of care: general methodology and applications in nephrology","volume":"3","author":"Esposito P","year":"2014","unstructured":"Esposito P, Dal Canton A. Clinical audit, a valuable tool to improve quality of care: general methodology and applications in nephrology. World J Nephrol. 2014, 3:249-55. 10.5527\/wjn.v3.i4.249","journal-title":"World J Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/505597-audit-of-retinal-screening-protocol-adherence-among-patients-receiving-hydroxychloroquine-at-the-department-of-rheumatology-gulab-devi-teaching-hospital-pakistan","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:01:36Z","timestamp":1788296496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/505597-audit-of-retinal-screening-protocol-adherence-among-patients-receiving-hydroxychloroquine-at-the-department-of-rheumatology-gulab-devi-teaching-hospital-pakistan"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.115611","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}